Stock Price
2.39
Daily Change
-0.08 -3.24%
Monthly
-12.77%
Yearly
-18.15%
Q1 Forecast
2.48

Mesoblast reported $597.44M in Equity Capital and Reserves for its fiscal semester ending in June of 2025.





Equity Capital And Reserves Change Date
Avita Medical AUD -12.89M 17.39M Jun/2025
Clinuvel Pharmaceuticals AUD 203.01M 24.36M Jun/2024
Cochlear AUD 1.95B 82.7M Jun/2025
CSL USD 21.41B 861M Jun/2025
Pacific Edge NZD 26.9M 811K Dec/2025
Paradigm Biopharmaceuticals AUD 21.18M 12.88M Jun/2025
PYC Therapeutics AUD 170.01M 114.57M Jun/2025
Ramsay Health Care AUD 5.71B 894M Jun/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Starpharma Holdings AUD 19M 4.17M Jun/2025
Telix Pharmaceuticals AUD 568.21M 164.24M Dec/2024